Related references
Note: Only part of the references are listed.Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease
Corrado Campochiaro et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
The genomic and transcriptional landscape of primary central nervous system lymphoma
Josefine Radke et al.
NATURE COMMUNICATIONS (2022)
Evidence of a common cell origin in a case of pancreatic mixed intraductal papillary mucinous neoplasm-neuroendocrine tumor
Marco Schiavo Lena et al.
VIRCHOWS ARCHIV (2021)
Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1
Jerome Razanamahery et al.
HAEMATOLOGICA (2020)
Rosai-Dorfman disease: an overview
Cassandra Bruce-Brand et al.
JOURNAL OF CLINICAL PATHOLOGY (2020)
Central nervous system involvement in Erdheim-Chester disease An observational cohort study
Fleur Cohen Aubart et al.
NEUROLOGY (2020)
Highly sensitive methods are required to detect mutations in histiocytoses
Sarah Melloul et al.
HAEMATOLOGICA (2019)
Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA
Shu Yi Shen et al.
NATURE PROTOCOLS (2019)
Superior efficacy and tolerance of reduced doses of vemurafenib plus anakinra in Erdheim-Chester disease: Towards the paradigm of combined targeting and immune therapies
Frederic Franconieri et al.
ACTA ONCOLOGICA (2016)
Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies
Parisa Momtaz et al.
ONCOTARGET (2016)
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
Leticia De Mattos-Arruda et al.
NATURE COMMUNICATIONS (2015)
Prospective Blinded Study of BRAFV600E Mutation Detection in Cell-Free DNA of Patients with Systemic Histiocytic Disorders
David M. Hyman et al.
CANCER DISCOVERY (2015)
BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease
Filip Janku et al.
ONCOTARGET (2014)
Diagnosis and management of Rosai-Dorfman disease involving the central nervous system
Amos O. Adeleye et al.
NEUROLOGICAL RESEARCH (2010)
Share Paper
